Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02819323 · ClinicalTrials.gov registry record · Phase 3
A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy
A Phase 3 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 91
- Enrollment target
NCT02819323 is a Phase 3 study that has completed, run by Braintree Laboratories. The registered enrollment target is 91 participants.
The verdict
NCT02819323, a Phase 3 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 91 participants
- Enrollment target
Study Summary
The objective of this study is to compare the safety, tolerance and efficacy of BLI800 to a PEG based preparation prior to colonoscopy in adolescent patients.
Interventions
- DRUG BLI800
- DRUG PEG-ELS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-03-27 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02819323
The ClinicalTrials.gov registry entry for NCT02819323 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BLI800 is the first listed.
NCT02819323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02819323 about?
NCT02819323 is a clinical study titled "A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy". The objective of this study is to compare the safety, tolerance and efficacy of BLI800 to a PEG based preparation prior to colonoscopy in adolescent patients.
What is the current status of trial NCT02819323?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 91 participants. The study started on 2016-06. Estimated completion is 2018-03-27.
What interventions are being tested in trial NCT02819323?
The interventions under investigation include: BLI800 (DRUG), PEG-ELS (DRUG).
Who is sponsoring clinical trial NCT02819323?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.